GitHub

Entropy-Foundation/supra-python-sdk

If you found a bug or would like to request a feature, please file an issue. If, based on the discussion on an issue, you would like to offer a code change, please make a pull request.
TMCnet

AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth

Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the AACR ...
IEEE

TV-L1 Optical Flow based Hierarchical Transformer Network for Micro-Expression Recognition

Abstract: Accurate interpretation of human emotions and micro-expressions is vital for advancing human-computer interaction, enhancing security systems, and supporting psychological research.
Targeted Oncology

EV-202: EV/Pembro Combo Shows 39% ORR in First-Line PD-L1+ HNSCC

Enfortumab vedotin and pembrolizumab combination achieved a 39% objective response rate in PD-L1 positive recurrent/metastatic HNSCC patients. Disease control rate was 75.6%, with responses observed ...
Frontiers

Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy

Background: Programmed cell death-ligand 1 (PD-L1) immunohistochemical expression currently is the only approved useful biomarker associated with the PD-1/PD-L1 immune checkpoint blockade (ICB) ...